Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 SEK | -2.70% | -8.54% | +30.62% |
Sales 2024 * | 266M 24.28M | Sales 2025 * | 136M 12.38M | Capitalization | 701M 63.99M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -72M -6.57M | EV / Sales 2024 * | 1.52 x |
Net cash position 2024 * | 298M 27.17M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.17 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-2.91
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
Latest transcript on Alligator Bioscience AB
1 day | -2.70% | ||
1 week | -8.54% | ||
Current month | -9.46% | ||
1 month | -4.56% | ||
3 months | -30.02% | ||
6 months | +132.86% | ||
Current year | +30.62% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 19-05-08 |
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.9 | -2.70% | 413 942 |
24-04-29 | 0.925 | 0.00% | 195,044 |
24-04-26 | 0.925 | +1.09% | 808,960 |
24-04-25 | 0.915 | -0.54% | 1,694,028 |
24-04-24 | 0.92 | -6.50% | 2,734,872 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 06:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.62% | 64.16M | |
+1.77% | 42.86B | |
+44.64% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- ATORX Stock